胡元佳
副教授

學歷 | 主講科目 | 學術研究 | 科研論著 | 社會服務 | 聯絡方法


學歷


主講科目

本科課程

研究生課程


學術研究

研究方向

研究團隊

T. Scherngell;宿凌;

倪靜雲張倩茹孔祥軍;林匯亨;左華麗;

·         碩士生

黃踔基田思齊;郭楊;文詩雅;郭慶華徐嘉辰丁凡尤晗;吳玉丹;曹晨;耿曉眉梁紅玉鄧俊靈趙君睿司徒嘉穎;萬苗;李朋朋;

 

鑒於跨學科合作在新知識時代的重要性,熱忱歡迎藥學、中藥學、生物技術、信息學、經濟學、管理學或相關學科背景的學生和研究人員申請博士課程、碩士課程、博士後或研究助理,加入我們的研究團隊。詳情請電郵至yuanjiahu@umac.mo聯絡。


科研論著

代表性期刊論文(總計80余篇;*通訊作者)

1        F.Ding, Q.R. Zhang, C.O.L. Ung, Y.T. Wang, Y.F. Han, Y.J. Hu*, J. Qi, An analysis of chemical ingredients network of Chinese herbal formulae for the treatment of coronary heart disease, Plos One, 10(2): e0116441, 2015.

2        X.J. Kong, Y.J. Hu*, Z.F. Cai, F.Q. Yang, Q.R. Zhang, Dendritic-cell-based technology landscape: Insights from patents and citation networks, Human Vaccines & Immunotherapeutics, 11(3):682-688, 2015.

3        X.J. Kong, W.X. Zhou, J.B. Wan, Q.R. Zhang, J.Y. Ni, Y.J. Hu*, An integrative thrombosis network: Visualization and topological analysis. Evidence-Based Complementary and Alternative Medicine, 2: 265303, 2015.

4        H. You., M. Barber, T. Scherngell, J.Y. Ni, Y.J. Hu*, China’s landscape in oncology drug research: Perspectives from research collaboration networks. Chinese Journal of Cancer Research, 27(2):138-147, 2015.

5        Y.J. Hu, T. Scherngell, L. Qiu, Y.T. Wang, R&D internationalisation patterns in the global pharmaceutical industry: Evidence from a network analytic perspective. Technology Analysis & Strategic Management, 27(5):532-549, 2015.

6        J.Y. Ni, R. Shao, C.O.L. Ung, Y.T. Wang, Y.J Hu*, Y. Cai, Valuation of pharmaceutical patents: A comprehensive analytical framework based on technological, commercial, and legal factors. Journal of Pharmaceutical Innovation, 10(3):281-285, 2015.

7        X.M. Geng, X.J. Kong, H. Hu, J.Y. Chen, F.Q. Yang, H.Y. Liang, X. Chen, Y.J. Hu*, Research and development of therapeutic mAbs: An analysis based on pipeline projects, Human Vaccines & Immunotherapeutics, 11(12):2769-2776, 2015.

8        J.Y. Ni, J.B. Wan, X.J. Kong, Y. Cai, F.Q. Yang, Y.T. Wang, Y.J. Hu*, Pharmaceutical technology licensing: An analysis in the field of cardiovascular disease, Journal of Pharmaceutical Innovation, 9(30):1-12, 2015.

9        J.C. Xu, X. J. Kong, L. Qiu, X. M. Geng, Y.J. Hu*, Y.T. Wang, Research and development of anti-Alzheimer’s drugs: An analysis based on technology flows measured by patent citations, Expert Opinion on Therapeutic Patents, 7: 1-10, 2014.

10    T. Scherngell, M. Borowiecki, Y.J. Hu, Effects of knowledge capital on total factor productivity in China: a spatial econometric perspective, China Economic Review, 29: 82-94, 2014.

11    Y.J. Hu*, T. Scherngell, S. N. Man, Y.T. Wang, Is the United States still dominant in the global pharmaceutical innovation network? Plos One, 8(11), e77247, 2013.

12    Y. Guo, Y.J. Hu*, Y.T. Wang, Patent indicators: A window on pharmaceutical market value, Expert Opinion on Therapeutic Patents, 6: 1-6, 2013.

13    J.Y. Ni, J.C. Xu, Y.J. Hu*, L. Su, Y.T. Wang, Cross-regional pharmaceutical technology transfer in China: Patterns and proposed investment strategies, Therapeutic Innovation & Regulatory Science, 8: 1-10, 2013.

14    L. Su, T. Li, Y.J. Hu, J.Y. Chen, Factor analysis on marketing mix of online pharmacies: Based on the online pharmacies in China, Journal of Medical Marketing, 13(2): 93-101, 2013.

15    J.J. Lu, W. Pan, Y.J. Hu*, Y.T. Wang, Multi-target drugs: The trend of drug research and development, Plos One, 7(6): 1-6, 2012.

16    T. Scherngell and Y.J. Hu, Collaborative knowledge production in China: Regional evidence from a gravity model approach, Regional Studies, 45: 755-772, 2011.

17    Y.J. Hu, Y. Bian, Y.T. Wang, Opening the “black box” of pharmaceutical patent value: An empirical analysis, Drug Information Journal, 42(6): 561-568, 2008.

18    Y.J. Hu, C. O. L. Ung, Y. Bian, Y.T. Wang, The Chinese pharmaceutical market: Dynamics and a proposed investment strategy (Best Paper Award in 2007), Journal of Medical Marketing, 7(1): 18-24, 2007.

19    Y.J. Hu, F. Geng, Y. Bian, Y.T. Wang, The Chinese pharmaceutical market: Perspectives of the health consumer, Journal of Medical Marketing, 7(4): 295-300, 2007.

20    Y.J. Hu, Y. Bian, Y.T. Wang, Secrets of blockbuster drugs: Data mining for oppositions against patents, Drug Information Journal, 41(3): 425, 2007.

書籍章節

1          H.W. Kuok, X.J. Kong, Y.J. Hu*, Y.T. Wang, Discovering MiRNAs in Cancer: China's Landscape and the Role of Hong Kong, in Biotechnology in Hong Kong, United States-China Intellectual Property Institute, Hong Kong, 2015.

2          于元元, 劉京京, 邱嵐, 潘威, 胡元佳, 王一濤. “抗腫瘤中藥市場與知識產權現狀和展望”, 《中藥抗腫瘤現代研究技術與進展》, 人民衛生出版社, 北京, 2013.

3          王一濤, 卞鷹, 李玲, 胡元佳. “澳門衛生醫療發展”, 《澳門藍皮書――澳門經濟社會發展報告2010, 社會科學文獻出版社, 北京, 2010.

4          胡元佳, 邵蓉, 宋瑞霖, 卞鷹, 史錄文, 王一濤. “中國醫藥產業的產業政策法研究”, 《中華醫藥叢書A――醫藥管理研究進展》, 澳門大學出版, 澳門, 2005.

會議論文

1          Study on therapeutic targets networks of Xuefu-zhuyu decoction and Gualou-xiebai-banxia decoction for the treatment of coronary artery disease, 13th Annual Conference of Chinese Pharmacological Society, Beijing, November 2015.

2          Network-based identification of therapeutic targets from traditional herbal formulae, 7th Asian Association of Schools of Pharmacy (AASP) Conference, Taipei, Taiwan, October 2015.

3         Cross-regional pharmaceutical development in China: An empirical study based on technology transfer, 14th Meeting of Consortium for Globalization of Chinese Medicine (CGCM), London ON, Canada, August 2015.

4         Patent: A powerful indicator to measure drug innovation, Annual Meeting of Law Offices of Albert Wai-Kit Chan, Hong Kong, August 2014.

5         Effects of knowledge capital on total factor productivity in China: A spatial econometric perspective, The 53rd European Regional Science Association Congress, Palermo, Italy, August 2013.

6         Correlation between drug licensing and economic output: evidence from 151 drugs marketed in USA? The 24th Annual EuroMeeting of Drug Information Association, Copenhagen, Denmark, March 2012.

7         What determines pharmaceutical business value: evidence from 127 drugs marketed in USA? 10th Meeting of Consortium for Globalization of Chinese Medicine, Shanghai, August 2011.

8         R&D collaboration networks of Chinese universities in medical field: An empirical analysis based on informetrics, 2011 IEEE International Symposium on IT in Medicine & Education, Guangzhou, China, December 2011.

9         Pharmaceutical patent valuation: Novel models and applications in industry, The 46th Annual Meeting of U.S. Drug Information Association, Washington, D.C. USA, June 2010 (Session Chair).

10     A look at China’s pharmaceutical market, A Workshop on New Paradigms in Life Sciences Marketing by European Business School INSEAD, Paris, France, March 2007.


社會服務

1.       國家藥物政策與醫藥產業經濟研究中心項目研究員(2015至今)

2.       世界中醫藥學會聯合會網絡藥理學專業委員會副秘書長(2015至今)

3.       世界中醫藥學會聯合會信息專業委員會理事(2015至今)

4.       澳門大學曹光彪書院導師(2015至今)

5.       中國藥理學會網絡藥理學專業委員會委員(2014至今)

6.       澳門社會科學學會會員(2010至今)

7.       澳門藥學會會員(2009至今)

8.       國際中醫藥學會會員(2008至今)


聯絡方法

澳門大學中華醫藥研究院
大學大馬路
中國澳門氹仔

222053
電話 :(853) 8822-8507
傳真 :(853) 2884-1358
電子郵件: yuanjiahu@umac.mo